GB8814604D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB8814604D0
GB8814604D0 GB888814604A GB8814604A GB8814604D0 GB 8814604 D0 GB8814604 D0 GB 8814604D0 GB 888814604 A GB888814604 A GB 888814604A GB 8814604 A GB8814604 A GB 8814604A GB 8814604 D0 GB8814604 D0 GB 8814604D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
treatment
human beings
bolus injections
thrombotic disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888814604A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10638996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB8814604(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB888814604A priority Critical patent/GB8814604D0/en
Publication of GB8814604D0 publication Critical patent/GB8814604D0/en
Priority to AT89306180T priority patent/ATE74275T1/de
Priority to EP89306180A priority patent/EP0352897B1/en
Priority to CA000603175A priority patent/CA1338551C/en
Priority to DK198903015A priority patent/DK175179B1/da
Priority to ZA894647A priority patent/ZA894647B/xx
Priority to AU36584/89A priority patent/AU612267B2/en
Priority to JP1154761A priority patent/JPH0618782B2/ja
Priority to NZ229611A priority patent/NZ229611A/en
Priority to IE197789A priority patent/IE61399B1/en
Priority to ES198989306180T priority patent/ES2033096T3/es
Priority to DE8989306180T priority patent/DE68901114D1/de
Priority to GR920400550T priority patent/GR3004181T3/el
Priority to US07/994,083 priority patent/US5342616A/en
Priority to HK46597A priority patent/HK46597A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicinal Preparation (AREA)
GB888814604A 1988-06-20 1988-06-20 Medicaments Pending GB8814604D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB888814604A GB8814604D0 (en) 1988-06-20 1988-06-20 Medicaments
ES198989306180T ES2033096T3 (es) 1988-06-20 1989-06-19 Medicamentos que contienen activador de plasminogeno de tejidos.
DE8989306180T DE68901114D1 (de) 1988-06-20 1989-06-19 Tpa enthaltende arzneimittel.
ZA894647A ZA894647B (en) 1988-06-20 1989-06-19 Medicaments
NZ229611A NZ229611A (en) 1988-06-20 1989-06-19 A bolus formulation containing at least 12.5 mu of t-pa
CA000603175A CA1338551C (en) 1988-06-20 1989-06-19 Medicament for thrombotic disorder containing t-pa
DK198903015A DK175179B1 (da) 1988-06-20 1989-06-19 Anvendelse af et t-PA til fremstilling af et lægemiddel til behandling af thrombotisk forstyrrelser
AT89306180T ATE74275T1 (de) 1988-06-20 1989-06-19 Tpa enthaltende arzneimittel.
AU36584/89A AU612267B2 (en) 1988-06-20 1989-06-19 Medicaments
JP1154761A JPH0618782B2 (ja) 1988-06-20 1989-06-19 組織プラスミノーゲン活性化因子製剤
EP89306180A EP0352897B1 (en) 1988-06-20 1989-06-19 Tpa-containing medicaments
IE197789A IE61399B1 (en) 1988-06-20 1989-06-19 TPA-Containing medicaments
GR920400550T GR3004181T3 (enExample) 1988-06-20 1992-03-27
US07/994,083 US5342616A (en) 1988-06-20 1992-12-16 Method of administering tissue plasminogen activator
HK46597A HK46597A (en) 1988-06-20 1997-04-10 TPA-containing medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888814604A GB8814604D0 (en) 1988-06-20 1988-06-20 Medicaments

Publications (1)

Publication Number Publication Date
GB8814604D0 true GB8814604D0 (en) 1988-07-27

Family

ID=10638996

Family Applications (1)

Application Number Title Priority Date Filing Date
GB888814604A Pending GB8814604D0 (en) 1988-06-20 1988-06-20 Medicaments

Country Status (14)

Country Link
EP (1) EP0352897B1 (enExample)
JP (1) JPH0618782B2 (enExample)
AT (1) ATE74275T1 (enExample)
AU (1) AU612267B2 (enExample)
CA (1) CA1338551C (enExample)
DE (1) DE68901114D1 (enExample)
DK (1) DK175179B1 (enExample)
ES (1) ES2033096T3 (enExample)
GB (1) GB8814604D0 (enExample)
GR (1) GR3004181T3 (enExample)
HK (1) HK46597A (enExample)
IE (1) IE61399B1 (enExample)
NZ (1) NZ229611A (enExample)
ZA (1) ZA894647B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0580685T3 (da) * 1991-04-16 1996-03-04 Boehringer Mannheim Gmbh Farmaceutisk emballageenhed indeholdende plasminogenaktivatorer til flerfoldig bolusindgift
DK125693D0 (enExample) * 1993-11-05 1993-11-05 Novo Nordisk As

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO171344C (no) * 1985-05-28 1993-03-03 Wellcome Found Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
EP0218112B1 (en) * 1985-09-10 1992-12-09 Eisai Co., Ltd. Composition containing tissue plasminogen activator
EP0252004A1 (de) * 1986-06-26 1988-01-07 Ciba-Geigy Ag Pharmazeutische Zusammensetzungen für die parenterale Applikation

Also Published As

Publication number Publication date
GR3004181T3 (enExample) 1993-03-31
IE891977L (en) 1989-12-20
ATE74275T1 (de) 1992-04-15
JPH0618782B2 (ja) 1994-03-16
AU612267B2 (en) 1991-07-04
AU3658489A (en) 1990-01-11
ZA894647B (en) 1991-02-27
DK301589A (da) 1989-12-21
DK301589D0 (da) 1989-06-19
CA1338551C (en) 1996-08-27
EP0352897B1 (en) 1992-04-01
NZ229611A (en) 1991-12-23
JPH0272124A (ja) 1990-03-12
HK46597A (en) 1997-04-18
DE68901114D1 (de) 1992-05-07
EP0352897A1 (en) 1990-01-31
IE61399B1 (en) 1994-11-02
ES2033096T3 (es) 1993-03-01
DK175179B1 (da) 2004-06-28

Similar Documents

Publication Publication Date Title
DE3878889D1 (de) Packung und verpackung mit sauerstoff absorbierenden mitteln.
EP0318201A3 (en) Inhibition of arterial thrombotic occlusion or thromboembolism
HUT59017A (en) Injection syringe
GB9100677D0 (en) Hypodermic syringe
EP0381697A4 (en) Self-blunting needle assembly and device including the same
EP0279583A3 (en) Syringe needle combination
EP0602882A3 (en) Safety syringe.
SG42984A1 (en) Safety needle syringe
GB8802349D0 (en) Ampoule with luer
ATE104151T1 (de) Trombosebehandlung mit fibrinolytika und prostacyclinen.
GB8914684D0 (en) Hypodermic needle and case assembly
DE68922588D1 (de) Verbinder mit abnehmbarem Verriegelteil und Verriegelteil dafür.
EP0200156A3 (en) Use of an aqueous solution of a chlorite matrix for treating tumours
NZ230327A (en) Synergistic combination of t-pa and activated protein c (apc)
IE891977L (en) Medicaments
ZA857721B (en) Process for treatment of rheumatic diseases
EP0333831A4 (en) USE OF METALLOPORPHYRIN TO REVERSE THE TOXIC EFFECT OF TUMOR THERAPY.
EP0505579A4 (en) Injector supplied with medicine
FR2578255B1 (fr) Acides 8-oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxyliques a action therapeutique
HU906697D0 (en) Analgesic and inflammation-suppressing medicament
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
GB9000761D0 (en) Syringe needle with safety feature
GR3005387T3 (enExample)
ZA888714B (en) Medicament with antiemetic action
AU104178S (en) A sulky wheel